ATE177472T1 - Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen - Google Patents

Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen

Info

Publication number
ATE177472T1
ATE177472T1 AT91916801T AT91916801T ATE177472T1 AT E177472 T1 ATE177472 T1 AT E177472T1 AT 91916801 T AT91916801 T AT 91916801T AT 91916801 T AT91916801 T AT 91916801T AT E177472 T1 ATE177472 T1 AT E177472T1
Authority
AT
Austria
Prior art keywords
mip
expression
mips
macrophage
yeast cells
Prior art date
Application number
AT91916801T
Other languages
English (en)
Inventor
Patricia Tekamp-Olson
Carol Ann Gallegos
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE177472T1 publication Critical patent/ATE177472T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT91916801T 1990-09-14 1991-09-13 Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen ATE177472T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58263690A 1990-09-14 1990-09-14

Publications (1)

Publication Number Publication Date
ATE177472T1 true ATE177472T1 (de) 1999-03-15

Family

ID=24329903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916801T ATE177472T1 (de) 1990-09-14 1991-09-13 Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen

Country Status (7)

Country Link
US (1) US5814484A (de)
EP (1) EP0548214B1 (de)
JP (1) JPH06503710A (de)
AT (1) ATE177472T1 (de)
CA (1) CA2091266A1 (de)
DE (1) DE69130981D1 (de)
WO (1) WO1992005198A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
AU679436B2 (en) * 1991-12-23 1997-07-03 British Bio-Technology Limited Stem cell inhibiting proteins
GB9308060D0 (en) * 1993-04-19 1993-06-02 Cancer Res Campaign Tech Stem cell inhibitor
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
EP0733109B9 (de) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
WO1995017092A1 (en) * 1993-12-22 1995-06-29 Human Genome Sciences, Inc. MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US5556767A (en) * 1993-12-22 1996-09-17 Human Genome Sciences, Inc. Polynucleotide encoding macrophage inflammatory protein γ
US5504003A (en) * 1994-03-08 1996-04-02 Human Genome Sciences, Inc. Macrophage inflammatory protein-3 and -4
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
WO1996006169A1 (en) 1994-08-23 1996-02-29 Human Genome Sciences, Inc. Human chemokine beta-9
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
CN1125082C (zh) * 1995-05-05 2003-10-22 人类基因组科学公司 人类趋化因子β-8,趋化因子β-1和巨噬细胞炎性蛋白-4
GB9600559D0 (en) * 1996-01-11 1996-03-13 British Biotech Pharm Use of chemokines
ZA97990B (en) * 1996-02-09 1997-08-06 Schering Corp Mammalian dendritic cell chemokine reagents.
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
US6121023A (en) * 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP1223990B1 (de) 1999-10-15 2004-07-28 Genetics Institute, LLC Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
ATE518884T1 (de) 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
MX361929B (es) 2010-11-19 2018-12-19 Eisai R&D Man Co Ltd Star Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69026B1 (en) * 1987-06-12 1996-08-07 Immuno Ag Novel proteins with factor VIII activity process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
DE3855802T2 (de) * 1987-10-02 1997-06-12 The Rockefeller University, New York, N.Y. Von Makrophagen abstammender Entzündungsvermittler(MIP-1-alpha et MIP-1-beta)
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them
DE69020573T3 (de) * 1989-09-25 1999-12-16 Crc Technology Ltd., London Verfahren zur wachstumshemmung von stammzellen.

Also Published As

Publication number Publication date
EP0548214A1 (de) 1993-06-30
CA2091266A1 (en) 1992-03-15
US5814484A (en) 1998-09-29
WO1992005198A1 (en) 1992-04-02
EP0548214B1 (de) 1999-03-10
DE69130981D1 (de) 1999-04-15
JPH06503710A (ja) 1994-04-28

Similar Documents

Publication Publication Date Title
DE69130981D1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
FI873162A7 (fi) Menetelmä faktori VIII aktiviteetin omaavien proteiinien valmistamiseksi käyttäen mikrobi-isäntäsoluja; ekspressiovektorit, isäntäsolut, vasta-aineet
DK506488D0 (da) Fremgangsmaade til dyrkning af rekombinante celler, vaertscelle til anvendelse ved fremgangsmaaden og kultur omfattende vaertscellen
NO973848D0 (no) Fremgangsmåte til fremstilling av hemoglobinliknende protein
FI852547L (fi) Framstaellning av faktor viii och daertill hoerande produkter.
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
ATE158816T1 (de) Expression von pace in wirtszellen und verfahren zu dessen verwendung
DK1724354T3 (da) Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi
DE3786592D1 (de) Transformation von trichoderma.
NO982672L (no) FremgangsmÕte for fremstilling av rekombinante proteiner i E. coli ved fermentering med h°y celletetthet
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
DE68929134D1 (de) Endothelin-DNA und Verwendung davon
ATE79403T1 (de) Herstellung von thrombin-inhibitoren.
NZ211357A (en) Recombinant dna and antigenic protein coded for
EP0182448A3 (de) Verfahren zur Herstellung von Faktor VIII und verwandte Produkte
DE69329190D1 (de) Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
IL92685A0 (en) Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
FI873153L (fi) Menetelmä ihmisen antitrombiini III:n (ATIII:n) valmistamiseksi nisäkässoluviljelmässä sekä tähän soveltuvia vektoreita ja nisäkäsisäntäsoluja
ATE288476T1 (de) Herstellung von proteinen
ZA875267B (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties